择期腹主动脉瘤修复中EVAR逐步采用的影响:2009-2015年回顾性队列研究
该回顾性队列研究纳入2009-2015年单中心211例择期腹主动脉瘤修复患者,比较EVAR与开放手术(OSR)的结局。EVAR患者年龄更大、合并症更多,但住院时间更短、30天并发症更低、主动脉相关死亡率更低,倾向评分调整后再干预率相似。随时间EVAR成为主要修复方式,并发症和30天死亡率均下降。
要点
- EVAR患者年龄更大且合并症更多,但住院时间更短、30天并发症更低。
- 倾向评分调整后EVAR再干预率与OSR相似,主动脉相关死亡率更低。
- 研究期间EVAR逐渐成为主要修复方式,并发症和30天死亡率随时间下降。
核心结论
- 尽管EVAR患者合并症更多,但EVAR取得了更好且持久的结局,支持其用于择期腹主动脉瘤修复。
研究设计与样本
- 单中心回顾性观察性队列研究,纳入2009-2015年连续择期腹主动脉瘤修复患者,排除非择期或复杂主动脉瘤病例,共211例。
主要发现
- EVAR患者年龄更大(74±7 vs. 67±9岁,P<0.001),高血压(83.5% vs. 68.5%,P=0.004)、肥胖(28.7% vs. 14.3%,P=0.029)、既往心脏血运重建(30.5% vs. 14.7%,P=0.005)、心力衰竭(17.2% vs. 5.2%,P=0.013)和慢性阻塞性肺疾病(32.8% vs. 13.3%,P=0.002)患病率更高。
- EVAR组住院时间更短(中位数4天,四分位距3 vs. 8(9);P<0.001),30天并发症更低(10.6% vs. 22.8%,P=0.017),主动脉相关死亡率更低,倾向评分调整后再干预率相似。
- 研究期间EVAR成为主要修复方式(P=0.024),并发症比例下降(P=0.014),30天死亡率下降(P=0.035)。
- 中位随访49个月。
临床怎么用
- 对于合并症较多的择期腹主动脉瘤患者,EVAR可缩短住院时间、降低30天并发症和主动脉相关死亡率,且再干预率与开放手术相似。
局限性
- 单中心回顾性观察性设计,可能存在选择偏倚和混杂,样本量有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The recommendations about the preferred type of elective repair of abdominal aortic aneurysm (AAA) still divides guidelines committees, even nowadays. The aim is to assess outcomes after AAA repair focusing on differences between endovascular aneurysm repair (EVAR) and open surgical repair (OSR). METHODS: The observational retrospective cohort study of consecutive patients submitted to elective AAA repair at a tertiary center, 2009-2015. Exclusion criteria were as follows: nonelective cases or complex aortic aneurysms. Primary outcomes were postoperative complications, length of hospital stay, survival, freedom from aortic-related mortality, and vascular reintervention. Time trends were assessed along the period under analysis. RESULTS: From a total of 211 included patients, those submitted to EVAR were older (74 ± 7 vs. 67 ± 9 years; P < 0.001), presented a higher prevalence of hypertension (83.5% vs. 68.5%, P = 0.004), obesity (28.7% vs. 14.3%, P = 0.029), previous cardiac revascularization (30.5% vs. 14.7%, P = 0.005), heart failure (17.2% vs. 5.2%, P = 0.013), and chronic obstructive pulmonary disease (32.8% vs. 13.3%, P = 0.002). Patients were followed during a median of 49 months. EVAR resulted in a significantly shorter length of hospital stay (median 4 and interquartile range 3 vs. 8 (9); P < 0.001), lower 30-day complications (10.6% vs. 22.8%, P = 0.017), lower aortic-related mortality, and similar reintervention after adjustment with a propensity score. Along the time under analysis, EVAR became the predominate type of repair (P = 0.024), the proportion of complications decreased (P = 0.014), and the 30-day mortality (P = 0.035). CONCLUSIONS: Although EVAR was offered to patients with more comorbidities, better and durable outcomes were achieved after EVAR, favoring its adoption for elective AAA repair.
引用
- Dias-Neto M, Norton L, Sousa-Nunes F, et al. Impact of Gradual Adoption of EVAR in Elective Repair of Abdominal Aortic Aneurysm: A Retrospective Cohort Study from 2009 to 2015. Ann Vasc Surg. 2020. PMID: 32615203. doi:10.1016/j.avsg.2020.06.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。